Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
The First Affiliated Hospital of Soochow University
Roswell Park Cancer Institute
Cardiff University
M.D. Anderson Cancer Center
Gamida Cell -Teva Joint Venture Ltd.
Virginia Commonwealth University
Royal Marsden NHS Foundation Trust